NCT05095610View on ClinicalTrials.gov

Clinical Effects of Intermitent Continuous Glucose Monitoring in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

1,121

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

May 6, 2022

Conditions
Type 1 Diabetes
Interventions
DEVICE

Flash

Use of the device FreeStyle Libre, only commercialized system for intermitent continuous glucose monitoring.

Trial Locations (8)

13005

Obispo Rafael Torija, St., Ciudad Real

13300

Virgen de Altagracia Hospital, Valdepeñas

13500

Santa Barbara Hospital, Puertollano

13600

La Mancha- Centro Hospital, Alcázar de San Juan

19002

Guadalajara University Hospital, Guadalajara

45007

Toledo University Hospital, Toledo

45600

Virgen del Prado Hospital, Talavera de la Reina

02006

Albacete University Hospital, Albacete

All Listed Sponsors
lead

Castilla-La Mancha Health Service

OTHER

NCT05095610 - Clinical Effects of Intermitent Continuous Glucose Monitoring in Type 1 Diabetes | Biotech Hunter | Biotech Hunter